The first delivery of assets is scheduled for December 15th and will include CE marked finished goods lasers that SurgiLight can immediately sell to international clinical sites.
We are pleased to conclude this additional purchase from Premier. We have an immediate need for more CE marked OptiVision lasers," said Timothy Shea, SurgiLight COO. "The new technology should enhance our research and development programs. In addition, Premier's shareholder base, which will be receiving the SurgiLight shares as part of the purchase price, is perfectly tailored for our company because it consists of ophthalmologists and investors interested in laser companies. The Premier shareholder base of more than 10,000 shareholders will augment our current shareholder list, helping us reach one of the criteria for becoming a Nasdaq Small Cap stock."